K240348

Substantially Equivalent

Quantum Mitohormesis (QMT) (M2101)

Applicant: Quantumtx Pte. , Ltd.
Product code: IPF
Advisory panel: Physical Medicine
Date received: 2024-02-05
Decision date: 2024-12-19
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Singapore, SG

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.